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Background: Limited data suggested that the prevalence of Human Papillomavirus (HPV) among female sex
workers (FSW) is much higher than in the general female population. The current study aimed to examine the HPV
and cervical cancer related awareness, knowledge, and behaviors among FSW in China.
Methods: A total of 360 FSW recruited from entertainment establishments in Beijing completed a self-administered
survey including demographics, HPV related knowledge, and health-seeking and cervical cancer preventive
behaviors.
Results: Approximately 70.8% of the participants ever heard of cervical cancer, and as few as 22.1% and 13.3% ever
heard of HPV and HPV vaccine, respectively. The mean score on a 7-item knowledge scale was 2.2 (SD = 2.4). Less
than 10% of FSW perceived any risk of cervical cancer, and only 15.3% ever had a Pap smear. About 40.8% of FSW
would accept HPV vaccine if it is free, and 21.8% would accept it even with a charge. Multivariate regression
suggested that women with better knowledge of cervical cancer were more likely to have a Pap smear
(aOR = 1.35); women who had tested for HIV were 11 times more likely to have a Pap smear, and women who had
worked longer in commercial sex (aOR = 1.01) and had regular health check-ups (aOR = 1.95) were more likely to
accept HPV vaccine.
Conclusions: Our study underscores the needs for effective cervical cancer prevention programs for FSW in China
and other resource-limited countries. We specifically call for cervical cancer and HPV knowledge and awareness
programs and regular screening as well as HPV risk-reduction programs for these vulnerable women.
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Cervical cancer, the second most common female can-
cer, kills more than 275,000 women annually. More than
80% of cervical cancer occurs in women in developing
countries. As the most populous country, China has ob-
served an increase in the cervical cancer incidence rate in
younger females (25–44 years of age) within a context of a
growing cancer burden [1,2]. For instance, the incidence
rate of cervical cancer was 0.21 per 100,000 among
women aged 20 to 24 from 1988 to 1992, but jumped to
1.35 per 100,000 from 1998 to 2002. Nationwide organized* Correspondence: xiaoli@med.wayne.edu
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reproduction in any medium, provided the orcervical cancer screening is not available, but a recent
study reported that approximately 75,000 women devel-
oped cervical cancer and 40,000 women died from the dis-
ease each year [3].
Almost all cervical cancers are caused by human papil-
lomavirus (HPV) infection, one of the most common
sexually transmitted infections [4-6]. The prevalence of
HPV is higher in less developed countries (42.2%) than
in more developed regions (22.6%) and higher in women
who engage in sexual risk behaviors [7,8]. For instance,
having sexual intercourse at a younger age, increased
number of pregnancies, increased number of sexual
partners, unprotected sex, long-term use of hormonal
contraceptive [9], smoking, and experience of sexual vio-
lence were all recognized as significant risk factors fortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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individuals are more susceptible to a broader range of
HPV genotypes [12], the high prevalence of HIV [13,14]
contributes to a higher risk of HPV infection among
FSW [15]. Female sex workers (FSW) are at a very high
risk of HPV and cervical cancer because of their expos-
ure to multiple risks. Limited data suggested that the
prevalence of HPV in FSW is much higher than in the
general female population [16-19]. Some scholars sug-
gested that FSW are reservoirs of oncologic HPV, and
cervical cancer in monogamous women develops in part
as a result of transmission of these viruses to them by
their husbands from FSW [19]. Despite the evidence of
high prevalence of HPV in FSW, limited prevention pro-
grams are available for these vulnerable women. Assess-
ment of knowledge, awareness, and attitudes towards
cervical cancer and its prevention are necessary to de-
sign an effective prevention program. Some initiatives
have been explored for the purpose of designing effective
programs for the prevention of cervical cancer. For ex-
ample, in some developed countries, health professionals
have implemented screening programs among general
women and HPV vaccination programs among school-
based adolescent girls and found cervical cancer as well
as HPV-related diseases have been markedly prevented
[3,20-24], but programs targeting FSW have been very
limited [25,26].
In addition to an increasing cancer burden, the past
three decades have also witnessed the resurgence of
commercial sex in China because of widening income
disparities and changing sexuality [27]. An estimated
four to 10 million FSW work in a complex hierarchy of
sex industry [28]. Most of them are young women who
have limited education, have migrated from rural areas
to cities, and practice high rates of risky sexual behav-
iors. The prevalence of sexually transmitted infections
(STI) (e.g., syphilis, gonorrhea, chlamydia, herpes sim-
plex virus [HSV]) among them ranges from 13% to 42%
[28]. Most of the research on this population has fo-
cused on HIV/STI risks, but in recent years, new studies
have emerged in response to the growing concern of
HPV and cervical cancer in young women. A recent
study revealed that HPV prevalence among FSW in
China was about 38.9%; [29] however, virtually no data
were available regarding FSW’s knowledge, awareness,
and behaviors related to HPV and cervical cancer. The
current study aims to fill the gaps in the literature by an-
swering the following research questions: 1) What is the
level of awareness of cervical cancer, HPV, HPV vaccine
among FSW? 2) What is the level of knowledge of HPV
and cervical cancer among FSW? and 3) What are the
factors associated with cervical cancer preventive behav-
iors (i.e., Pap smear behavior and acceptance of the HPV
vaccine)?Methods
Participants
Data in the current study were collected in 2011 from
Chaoyang District in Beijing, China. Chaoyang District is
the most populous district in Beijing with a population
of about 3.64 million, including about 840,000 migrants.
The study participants were recruited from local enter-
tainment establishments (e.g., karaoke bars, massage
parlors) that were known to the local public health
agency for providing commercial sex services. Our re-
search staff approached owners or managers or other
gatekeepers of these venues to obtain their permission
to conduct research on their premises. Owners or man-
agers of a total of 15 establishments were approached,
and 11 of them agreed to participate. Once we received
permission, we then invited eligible women working in
these establishments to participate. Participation was
completely voluntary. Eligibility criteria included the fol-
lowing: 1) 18 years of age or older; 2) acknowledged
practice of commercial sex. A small number (3% to 8%
with a mean of 4%) of women we approached in each of
the 11 participating establishments refused to partici-
pate. A final sample of 360 women provided written in-
formed consent and completed a self-administered
confidential survey.
Survey procedure
The survey was conducted in separate rooms or private
spaces at the establishments where women were
recruited. No one was allowed to stay with participants
during the survey except the interviewer, who provided
assistance when necessary. All the interviewers had a
prior experience working with FSW. For some FSW who
never heard of cervical cancer, HPV, the HPV vaccine, or
the Pap smear, the interviewer explained the terms to
them before the FSW proceeded to the next question.
For FSW who had reading difficulty, the interviewer read
questions to them and recorded their oral responses in
the survey. The survey typically took about 45 minutes
to complete. Each participant received a research incen-
tive of 20 Chinese yuan (approximately US$3.00) and re-
imbursement for their transportation expenses (up to
US $5) upon the completion of the survey. The study
protocol, including the consent process, was approved
by the Institutional Review Board at Wayne State
University School of Medicine in the US and Beijing
Normal University in China.
Measures
Demographic characteristics measures include age (in
years), ethnicity (Han or ethnic minority), residency
(urban or rural), marital status (unmarried, married,
cohabited, divorced, or widowed), education (in years of
formal schooling), length of time working in the city (in
Table 1 Demographics of 360 study participants (N = 360)
Variable Value
Age (mean + SD), yr 25.1 (3.47)
Ethnicity
Han 91.1%
Non-Han 8.9%
Residency
Urban 35.8%
Rural 64.2%
Marriage status
Currently married 38.1%
Not currently married 61.9%
Education
Nine years schooling or less 58.1%
More than nine years of schooling 41.9%
Length of working in city (Mean, SD), month 50.4 (34.4)
Length of being FSWs (Mean, SD), month 20.5 (18. 6)
Monthly income (Mean, SD), 100 yuana 44.4 (22.6)
Had regular health check up 32 (9.1%)
Ever had HIV testing 59 (17.1%)
Note: a at the time of study, 6.5 yuan is equivalent to 1 US $.
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and monthly income (in Chinese currency yuan). For
the purpose of data analysis in the current study, we cat-
egorized ethnicity into Han and non-Han, educational
attainment into less than nine-year schooling verses at
least nine-year schooling, marital status into currently
not married (including divorced or widowed) verses cur-
rently married (including cohabited). In addition, we di-
vided FSW into two groups based upon the distribution
of their age: younger than 25 years old and 25 years of
age and older.
Health-seeking behaviors were measured using two
questions regarding whether the FSW ever had regular
health check-up or HIV testing (1 = yes, 0 = no).
Awareness. The participants were asked whether they
ever heard of cervical cancer, HPV, and the HPV vaccine
(1 = ever vs. 0 = never); they were also asked to rate their
perceived likelihood of getting cervical cancer (e.g., very
likely, likely, not likely, not likely at all). For the purpose
of data analysis, we assigned respondents who answered
“very likely” and “likely” into “high perceived risk of cer-
vical cancer” group; otherwise, we assigned them into
“low perceived risk of cervical cancer” group.
Knowledge of cervical cancer prevention and HPV was
measured using a 7-item scale. The scale was developed
based upon existing literatures [30,31] as well as a WHO
guideline on HPV and HPV vaccines [15]. The know-
ledge scale included questions regarding possible trans-
mission routes of HPV (e.g., sexual transmission), risk
factors of cervical cancer (e.g., early sex debut; HPV
infection), and preventive measures of cervical cancer
(e.g., annual Pap smear, HPV vaccination). For each
question, the response was coded as 1 = correct answer or
0 = incorrect answer. The composite score of the scale
was calculated by summing correct answers to all seven
questions with a higher score indicating a higher level of
cervical cancer knowledge. The Cronbach alpha for the
seven items was 0.87 in the current sample.
Questions on cervical cancer preventive behavior in-
cluded whether they ever had a Pap smear (1 = yes; 0 = no)
and whether they would have an HPV vaccination (yes if
free, yes even with a charge, and no). Respondents who an-
swered “yes if free” or “yes even with a charge” were cate-
gorized into “1 = willing to have an HPV vaccine” group;
otherwise, they are assigned into “0 = unwilling to have an
HPV vaccine”.
Data analysis
First, we conducted an exploratory data analysis to
examine the distribution of key demographic and back-
ground variables of interest in the current study. The
variables of interest included FSW’s demographic in-
formation and health-seeking behaviors. Second, we
employed Chi-square test and ANOVA to comparewomen’s awareness as well as knowledge and behav-
iors with regard to cervical cancer and HPV. For analysis
with knowledge, we only included responses from FSW
who were aware of cervical cancer or HPV. Third, univari-
ate logistic models and multivariate logistic models were
employed to examine the association of cervical cancer-
related preventive behaviors with key demographic and
awareness variables. The measures of preventive behaviors
(willingness of having an HPV vaccine and had a Pap
smear) were dichotomized to serve as dependent variables
in the logistic regression models. Demographic and back-
ground variables that were significantly associated with
the preventive behaviors (p < .05) in the univariate ana-
lyses were included in the multivariate models as inde-
pendent variables. Unadjusted odds ratios (ORs) and
adjusted odds ratios (aORs) from the logistic regression
models and their 95% confidence intervals (95% CIs) were
used to depict the relationship between cervical cancer-
related preventive behaviors and independent variables.
All statistical analyses were performed using SPSS 18.0.
Results
Table 1 presents demographic characteristics and health-
seeking behaviors of the sample. The mean age of the
FSW was 25.1 years (SD = 3.5, range:18–36 years old), a
majority (91.1%) of them were ethnic Han, 64.2% came
from rural areas, 61.9% were currently not married, and
58.1% had less than nine years of schooling. On average,
they have worked in the city for 50.4 months (SD = 34.4)
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monthly income was about 4,440 yuan (SD = 2,260). Ap-
proximately 17.1% of FSW ever had HIV testing, but
only 9.1% had regular health check-ups.
As shown in Table 2, 70.8% of FSW ever heard of cer-
vical cancer, 22.1% heard of HPV, and 13.3% heard of
the HPV vaccine. Less than 10% of FSW perceived any
risk of cervical cancer, and only 15.3% ever had a Pap
smear. About 62% of FSW were willing to have the HPV
vaccine, including 40.8% were willing if it is free and
21.4% were willing even if they have to pay. The distri-
bution of knowledge of cervical cancer and HPV was
examined in Table 3. Their responses to the 7-item
knowledge scale varied, with total scores ranging from 0
to 7 and a mean of 2.3 (SD = 2.3). Older FSW were less
aware of cervical cancer but for those who were aware,
they had better knowledge (see Tables 2 and 3).
Table 4 presents the outcomes of univariate logistic
regression and multivariate logistic regression with re-
gard to the factors associated with two key preventive
behaviors—ever had a Pap smear and willingness to
have an HPV vaccine. We found that, while control-
ling for confounders, cervical cancer-related know-
ledge (aOR = 1.35, 95% CI = 1.15, 1.59) and ever had
HIV testing (aOR = 11.14, 95% CI = 5.36, 23.15) were
the two significant correlates for Pap smear; having a
regular health check-up (aOR = 1.95, 95% CI = 1.01, 3.77)
and working longer in commercial sex (aOR = 1.01, 95%
CI = 1.00, 1.03) were significant correlates for acceptance
of HPV vaccine.
Discussion
This is one of the first studies that measures cervical
cancer and HPV- related knowledge, awareness, and be-
haviors among FSW in China. Our data revealed that
FSW in China had low levels of knowledge of cervical
cancer, HPV, and the HPV vaccine. Few FSW perceived
themselves at risk for cervical cancer despite their highTable 2 FSW’s awareness, perceptions, and behaviors on cerv
Item N (%) 18-24 years
Ever heard of cervical cancer 247(70.8%) 122 (77.7%)
Ever heard of HPV 76 (22.1%) 32 (20.5%)
Ever heard of HPV vaccine 46 (13.3%) 15 (9.4%)
Perceived at risk of cervical cancer 36 (10.0%) 17 (10.4%)
Ever had pap smear 54(15.3%) 19 (11.7%)
Wiling to have HPV vaccine
Willing even if not for free 73 (21.4%) 26 (16.9%)
Willing if free 139 (40.8%) 66 (42.9%)
No willing 129 (37.8%) 62 (40.3%)exposure to multiple sex partners and high rates of un-
protected sex. Only a small portion of FSW ever had a
Pap smear, but many were willing to take the HPV vac-
cine. The level of cervical cancer- and HPV-related
knowledge among FSW was lower than that of FSW in
other countries, such as Thailand and Peru [25,26]. as
well as general urban Chinese women [32]. For example,
a recent study among Peruvian FSW showed that 69.0%
of participants were aware of the transmission route of
HPV, compared to 26.3% in the current study [25]. An-
other study conducted in Thailand revealed that more
than half of FSW knew the possible consequences of
HPV infection, but less than one third of FSW in the
current study were aware of them [26].
Our data provide useful information for further re-
search and policy making. As China’s cancer burden
continues to grow, more attention has been directed to-
ward effective prevention programs [33]. Overall cervical
cancer mortality has been declining, but the declining
trends showed only for older women; younger women
showed an increasing trend [1]. Given the large popula-
tion and limited resources in most areas of China, iden-
tifying the most at-risk populations and designing
targeted prevention interventions are most efficient.
To date, no national cancer prevention program is
available in China despite several national and inter-
national efforts working towards this goal [33,34]. Most
urban women have access to cancer screening through
their employer-sponsored health insurance, but rural
women have had access to free cervical cancer screening
under a government-sponsored program only since 2009
[35]. The majority of FSW in China are rural-to-urban
migrants and not covered by any health insurance; fur-
thermore, the stigma against commercial sex has placed
them in “double jeopardy” [28]. In a study to examine
barriers to HIV testing, Hong and colleagues found that
perceived stigma and denial of risk were the major rea-
sons for not seeking testing [36]. The literature documentsical cancer and HPV (N = 360)
Age group
old (N = 163) 25 years and above (N = 197) p-value
125 (65.1%) 0.013
44 (23.4%) 0.602
31 (16.5%) 0.058
19 (9.6%) 0.861
35 (18.2%) 0.103
0.180
47 (25.1%)
73 (39.0%)
67 (35.8%)
Table 3 Knowledge on HPV infection, Pap smear, and cervical cancer (N = 256)a
Overall distribution (N = 256) Correct answers by age group, N (%)
Knowledge item (correct response) Yes No Don’t Know 18-24 years
old (N = 125)
25 years and
above (N = 131)
p-value
HPV is transmitted by sexual activities (yes) 77 (30.4%) 45 (17.8%) 131 (51.8%) 33 (26.4%) 44 (33.6%) 0.223
If a woman has an earlier sexual debut or has more sexual
partners, she is more likely to have cervical cancer (yes)
109 (42.9%) 39 (15.4%) 106 (41.7%) 48 (38.4%) 61 (46.6%) 0.207
HPV infection increased the likelihood of getting cervical
cancer (yes)
91 (35.5%) 13 (5.1%) 150 (59.1%) 36 (28.8%) 55 (42.0%) 0.036
Women should do pap smear once a year (yes) 106 (41.9%) 13 (5.1%) 134 (53.0%) 43 (34.4%) 63 (48.1%) 0.031
Women older than 21 yrs or have more than 3 yrs of sexual
activities, should do pap smear every year (yes)
105 (41.5%) 12 (4.7%) 136 (53.8%) 43 (34.4%) 62 (47.3%) 0.042
The best time for HPV vaccine is age 11 to 12 yrs old (yes) 31 (12.3%) 35 (13.9%) 186 (73.8%) 11 (8.8%) 20 (15.3%) 0.128
If a woman receives HPV vaccine, she doesn’t need to do pap
smear any more (no)
32 (12.6%) 65 (25.7%) 156 (61.7%) 30 (24.0%) 35 (26.7%) 0.668
Mean scoreb (SD, Range) 2.3 (2.3, 0–7) 2.0 (2.3,0-7) 2.6 (2.3,0-7) 0.026
Notes: a Only included women who were aware of cervical cancer and HPV (n = 256) in the knowledge assessment; b Mean score is the sum of the correct
responses to the seven items evaluating HPV knowledge.
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data from China showing an HPV prevalence of 39% in
FSW [11,16-19,29,32,37], which stands in sharp contrast
to the very low level of awareness, knowledge, and per-
ceived risk of cervical cancer in FSW in China. As demon-
strated in the current study, only 15% of FSW in China
ever had a Pap smear compared to 70% of their counter-
parts in Thailand [26]. We therefore call for policies and
programs to promote cervical cancer awareness and
screening in this population in China.
Empirical studies, including the ones conducted in
China, showed that early screening can efficiently reduce
cervical cancer mortality [23,24]. Several model-based
cost-effectiveness analyses suggested that HPV DNA
screening plus HPV vaccine in certain high-risk popula-
tion is the most effective approach to control cervical
cancer [38]. FSW are at high risk for cervical cancer, yet
they are highly mobile and severely stigmatized; thus,
prevention efforts to reduce cervical cancer morbidity
and mortality in this population deserve thoughtful plan-
ning and implementation. First, given the HPV vaccine
is designed to be prophylactic, it is most effective for
young women without previous or current infection
with vaccine-related HPV genotypes [15]. However, the
already-high HPV prevalence among FSW prevents the
vaccine from being effective among this population.
Therefore, it merits further research to explore the feasi-
bility of vaccinating young women, especially rural
women. Second, as a positive HPV test (especially HPV
DNA screening) will only tell the provider that a FSW is
HPV infected but not necessarily that she has cervical
dysplasia [29], we thus recommend that a positive HPV
test for a FSW should be used as a proxy for cervical ab-
normality and a cytology examination needs to be
performed on the HPV-positives. Third, our data indicatedthat ever had HIV testing was the most significant pre-
dictor of a Pap smear (aOR = 11). China has established a
comprehensive HIV voluntary counseling and testing
(VCT) program, and the service has been scaled up
to more than 6,000 clinics among all provinces na-
tionwide [39,40]. We thus suggest that cervical cancer
screening and counseling be integrated into the
existing VCT practice for women. Finally, FSW constitute
a highly heterogeneous population, and their risk behav-
iors vary considerably across age groups and working
venues; any prevention intervention programs must be
tailored to the subgroups to improve efficacy.
Our study has several limitations. First, our survey was
based on a closed-ended questionnaire; open-ended
questions might have gauged better cervical cancer-and
HPV-related awareness and perceptions, especially when
no prior data were available from this population. Sec-
ond, our study was based on a cross-sectional survey,
and the correlation observed in our data could not be
interpreted as a causal relationship. Finally, our sample
was a convenience community sample which may limit
our ability to generalize the findings to FSW populations
in other areas of China.
Conclusion
Our study examines HPV and cervical cancer related
knowledge, awareness and behaviors among FSW in
China. Despite being at high risk for HPV infection, they
have very low levels of knowledge and awareness of
cervical cancer and HPV; very low rates of Pap smears
and perceived risks have increased their actual risks.
These findings underscore the necessity and urgency of
targeted intervention. We call for culturally appropriate
programs to promote awareness of HPV and cervical
cancer and to provide access to low or no-cost cervical
Table 4 Multivariate predictors of having Pap smear and acceptance of HPV vaccine among FSW (N = 360)
Had a pap smear Willing to have an HPV vaccinea
Unadjusted OR
(95%CI)d
p-value Adjusted ORb
(95%CI) d
p-value Unadjusted OR
(95%CI)d
p-value Adjusted ORb
(95%CI)d
p-value
Age group 25 years of age and older 1.64 (0.90,2.99) 0.108 – n/a 1.20 (0.79,1.83) 0.391 – n/a
Younger than 25 years old 1.00 – 1.00 –
Ethnicity Han 0.35 (0.08,1.53) 0.164 – n/a 1.37 (0.64,2.93) 0.419 – n/a
Non-Han 1.00 – 1.00 –
Residency Rural 0.88 (0.48,1.62) 0.678 – n/a 0.86 (0.56,1.34) 0.508 – n/a
Urban 1.00 – 1.00 –
Marital status Currently married 0.95 (0.52,1.73) 0.867 – n/a 0.88 (0.57,1.35) 0.555 – n/a
Not current married 1.00 – 1.00 –
Education At least nine-year schooling 0.59 (0.32,1.09) 0.094 – n/a 0.96 (0.63,1.47) 0.841 – n/a
Less than nine-year schooling 1.00 – 1.00 –
Length of working (months)c 1.01 (1.00,1.02) 0.004 1.01 (1.00,1.02) 0.320 1.01 (1.00,1.01) 0.044 1.00 (1.00,1.01) 0.392
Length of working in commercial sex (months)c 1.03 (1.02,1.04) 0.000 1.01 (0.99,1.04) 0.224 1.02 (1.01,1.03) 0.005 1.01 (1.00,1.03) 0.044
Monthly income (per 100Yuan)c 1.02 (1.01,1.03) 0.005 1.00 (0.99,1.02) 0.605 1.00 (0.99,1.01) 0.437 – n/a
Perceived risk of cervical cancer High-perceived 1.15 (0.45,2.91) 0.768 – n/a 0.86 (0.43,1.72) 0.669 – n/a
Low perceived 1.00 – 1.00 –
Knowledge on HPV & cervical cancerc 1.52 (1.32,1.76) 0.000 1.35 (1.15,1.59) 0.000 1.08 (0.98,1.18) 0.133 – n/a
Had regular health check-up Yes 0.51 (0.24,1.12) 0.094 – n/a 2.09 (1.09,4.00) 0.027 1.95 (1.01,3.77) 0.047
No 1.00 – 1.00 1.00
Had HIV testing Yes 13.38 (6.88,26.02) 0.000 11.14 (5.36,23.15) 0.000 1.58 (0.87,2.85) 0.130 – n/a
No 1.00 1.00 1.00 –
Note: a Willingness to take an HPV vaccine combines those are willing to take the vaccine if free and those willing to take vaccine even if not for free; b Adjusted models only included statistically significant variables
in the unadjusted analyses; c Serving as continuous variables in the regression models; d 95%CI means 95% confidence interval.
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for young FSW.
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